NUR 641E CERTIFICATION SCRIPT 2026
COMPLETE QUESTIONS AND ANSWERS
◉ apixiban (MOA).
Answer: -Factor Xa inhibitor
-Eliquis
◉ Edoxaban (MOA).
Answer: -Factor Xa inhibitor
-Savaysa
◉ Rivaroxaban (MOA).
Answer: -factor Xa inhibitor
-Xarelto
◉ Fondaparinux (MOA).
Answer: -factor Xa inhibitor
-Arixtra
,◉ Pulmonary Embolism.
Answer: -usually a clot from the leg that blocks the pulmonary
vasculature
-affects right ventricle d/t backing up of blood
-can cause pulmonary hypertension
-risk factors: immobility, obesity, hormonal birth control, smoking,
HTN
◉ pulmonary hypertension.
Answer: -elevated pulmonary pressure resulting from an increase in
pulmonary vascular resistance to blood flow through small arteries
and arterioles.
-increased afterload causes increase in RV size as contractility
cannot overcome the resistance
◉ CVA (risk factors).
Answer: HTN, HLD, DM, Smoking, FHx CVA, Hx TIA/CVA, AFib
◉ action potential.
Answer: -sodium moves into cell (depolarization)
-threshold potential must be reached
-potassium moves out of cell (repolarization)
, -returns to resting potential by pumping sodium out of cell and
potassium back into cell
◉ threshold potential.
Answer: The minimum membrane potential that must be reached in
order for an action potential to be generated.
◉ absolute refractory period.
Answer: The minimum length of time after an action potential
during which another action potential cannot begin.
◉ relative refractory period.
Answer: A period after firing when a neuron is returning to its
normal polarized state and will fire again only if the incoming
message is much stronger than usual
◉ caseous necrosis.
Answer: -degeneration and death of tissue with a cheese-like
appearance
-associated with TB
◉ tuberculosis.
Answer: -An infectious disease that may affect almost all tissues of
the body, especially the lungs
COMPLETE QUESTIONS AND ANSWERS
◉ apixiban (MOA).
Answer: -Factor Xa inhibitor
-Eliquis
◉ Edoxaban (MOA).
Answer: -Factor Xa inhibitor
-Savaysa
◉ Rivaroxaban (MOA).
Answer: -factor Xa inhibitor
-Xarelto
◉ Fondaparinux (MOA).
Answer: -factor Xa inhibitor
-Arixtra
,◉ Pulmonary Embolism.
Answer: -usually a clot from the leg that blocks the pulmonary
vasculature
-affects right ventricle d/t backing up of blood
-can cause pulmonary hypertension
-risk factors: immobility, obesity, hormonal birth control, smoking,
HTN
◉ pulmonary hypertension.
Answer: -elevated pulmonary pressure resulting from an increase in
pulmonary vascular resistance to blood flow through small arteries
and arterioles.
-increased afterload causes increase in RV size as contractility
cannot overcome the resistance
◉ CVA (risk factors).
Answer: HTN, HLD, DM, Smoking, FHx CVA, Hx TIA/CVA, AFib
◉ action potential.
Answer: -sodium moves into cell (depolarization)
-threshold potential must be reached
-potassium moves out of cell (repolarization)
, -returns to resting potential by pumping sodium out of cell and
potassium back into cell
◉ threshold potential.
Answer: The minimum membrane potential that must be reached in
order for an action potential to be generated.
◉ absolute refractory period.
Answer: The minimum length of time after an action potential
during which another action potential cannot begin.
◉ relative refractory period.
Answer: A period after firing when a neuron is returning to its
normal polarized state and will fire again only if the incoming
message is much stronger than usual
◉ caseous necrosis.
Answer: -degeneration and death of tissue with a cheese-like
appearance
-associated with TB
◉ tuberculosis.
Answer: -An infectious disease that may affect almost all tissues of
the body, especially the lungs
